My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 309

    1.

    Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4(+)CD25(+) regulatory T-cells.

    Kared H, Masson A, Adle-Biassette H, Bach JF, Chatenoud L, Zavala F.

    Diabetes. 2005 Jan;54(1):78-84.PMID: 15616013 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells.

    Gaudreau S, Guindi C, Ménard M, Besin G, Dupuis G, Amrani A.

    J Immunol. 2007 Sep 15;179(6):3638-47.PMID: 17785799 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells.

    Luo X, Tarbell KV, Yang H, Pothoven K, Bailey SL, Ding R, Steinman RM, Suthanthiran M.

    Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2821-6. Epub 2007 Feb 16.PMID: 17307871 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.

    Mukherjee R, Chaturvedi P, Qin HY, Singh B.

    J Autoimmun. 2003 Nov;21(3):221-37.PMID: 14599847 [PubMed - indexed for MEDLINE]Related articles

    5.

    Improvement of heart allograft acceptability associated with recruitment of CD4+CD25+ T cells in peripheral blood by recipient treatment with granulocyte colony-stimulating factor.

    Liang HL, Yi DH, Zheng QJ, Du JF, Cao YX, Yu SQ, Zhu HL.

    Transplant Proc. 2008 Jun;40(5):1604-11.PMID: 18589159 [PubMed - indexed for MEDLINE]Related articles

    6.

    Modulation of dendritic cells using granulocyte-macrophage colony-stimulating factor (GM-CSF) delays type 1 diabetes by enhancing CD4+CD25+ regulatory T cell function.

    Cheatem D, Ganesh BB, Gangi E, Vasu C, Prabhakar BS.

    Clin Immunol. 2009 May;131(2):260-70. Epub 2009 Jan 25.PMID: 19171501 [PubMed - indexed for MEDLINE]Related articles

    7.

    Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells.

    Machen J, Harnaha J, Lakomy R, Styche A, Trucco M, Giannoukakis N.

    J Immunol. 2004 Oct 1;173(7):4331-41.PMID: 15383562 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Autoimmune diabetes is suppressed by transfer of proinsulin-encoding Gr-1+ myeloid progenitor cells that differentiate in vivo into resting dendritic cells.

    Steptoe RJ, Ritchie JM, Jones LK, Harrison LC.

    Diabetes. 2005 Feb;54(2):434-42.PMID: 15677501 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation.

    MacDonald KP, Rowe V, Filippich C, Thomas R, Clouston AD, Welply JK, Hart DN, Ferrara JL, Hill GR.

    Blood. 2003 Mar 1;101(5):2033-42. Epub 2002 Oct 17.PMID: 12393418 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Regulatory Th2 response induced following adoptive transfer of dendritic cells in prediabetic NOD mice.

    Feili-Hariri M, Falkner DH, Morel PA.

    Eur J Immunol. 2002 Jul;32(7):2021-30.PMID: 12115623 [PubMed - indexed for MEDLINE]Related articles

    11.

    Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.

    Tian B, Hao J, Zhang Y, Tian L, Yi H, O'Brien TD, Sutherland DE, Hering BJ, Guo Z.

    Transplantation. 2009 Jan 27;87(2):198-206.PMID: 19155973 [PubMed - indexed for MEDLINE]Related articles

    12.

    Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta?

    Song L, Wang J, Wang R, Yu M, Sun Y, Han G, Li Y, Qian J, Scott DW, Kang Y, Soukhareva N, Shen B.

    Gene Ther. 2004 Oct;11(20):1487-96.PMID: 15343360 [PubMed - indexed for MEDLINE]Related articles

    13.

    Thymic stromal lymphopoietin and thymic stromal lymphopoietin-conditioned dendritic cells induce regulatory T-cell differentiation and protection of NOD mice against diabetes.

    Besin G, Gaudreau S, Ménard M, Guindi C, Dupuis G, Amrani A.

    Diabetes. 2008 Aug;57(8):2107-17. Epub 2008 May 13.PMID: 18477807 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    IL-10-producing CD4+CD25+ regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis.

    Gangi E, Vasu C, Cheatem D, Prabhakar BS.

    J Immunol. 2005 Jun 1;174(11):7006-13.PMID: 15905543 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Immunomodulatory effect of decoy receptor 3 on the differentiation and function of bone marrow-derived dendritic cells in nonobese diabetic mice: from regulatory mechanism to clinical implication.

    Wu SF, Liu TM, Lin YC, Sytwu HK, Juan HF, Chen ST, Shen KL, Hsi SC, Hsieh SL.

    J Leukoc Biol. 2004 Feb;75(2):293-306. Epub 2003 Nov 21.PMID: 14634066 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes.

    Green EA, Gorelik L, McGregor CM, Tran EH, Flavell RA.

    Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10878-83. Epub 2003 Aug 29.PMID: 12949259 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Interleukin-7 is a survival factor for CD4+ CD25+ T-cells and is expressed by diabetes-suppressive dendritic cells.

    Harnaha J, Machen J, Wright M, Lakomy R, Styche A, Trucco M, Makaroun S, Giannoukakis N.

    Diabetes. 2006 Jan;55(1):158-70.PMID: 16380489 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo.

    Weber SE, Harbertson J, Godebu E, Mros GA, Padrick RC, Carson BD, Ziegler SF, Bradley LM.

    J Immunol. 2006 Apr 15;176(8):4730-9.PMID: 16585566 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Selective induction of dendritic cells using granulocyte macrophage-colony stimulating factor, but not fms-like tyrosine kinase receptor 3-ligand, activates thyroglobulin-specific CD4+/CD25+ T cells and suppresses experimental autoimmune thyroiditis.

    Vasu C, Dogan RN, Holterman MJ, Prabhakar BS.

    J Immunol. 2003 Jun 1;170(11):5511-22.PMID: 12759428 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    TGF-beta combined with M-CSF and IL-4 induces generation of immune inhibitory cord blood dendritic cells capable of enhancing cytokine-induced ex vivo expansion of myeloid progenitors.

    Li G, Abediankenari S, Kim YJ, Campbell TB, Ito S, Graham-Evans B, Cooper S, Broxmeyer HE.

    Blood. 2007 Oct 15;110(8):2872-9. Epub 2007 Jun 21.PMID: 17585053 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity